Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Urinary excretion of fluorescent advanced glycation end products (AGEs) in the elderly

  • 74 Accesses

  • 6 Citations

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. 1.

    Schleicher ED, Wagner E, Nerlich. Increased accumulation of the glycoxidation product Ne-(carboxymethyl)lysine in human tissues in diabetes and ageing. J Clin Invest 1999; 99: 457–468.

  2. 2.

    Chen J, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue S. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Reumatology 1999; 38: 1275–1278.

  3. 3.

    Vlitek P, Bhattacharya K; Glendening JM; Stopa E; Vlassara H; Bucala R; Manogue K, Cerami A: Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci 1994;91: 4766–4770.

  4. 4.

    Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 1986; 32: 37–41.

  5. 5.

    Zilin S, Naifeng L, Bicheng L, Jiping W. The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy. Clin Chim Acta 2001;313: 69–75.

  6. 6.

    Goldberg T, Cai W, Peppa M, Dardaine V, Suresh B, Uribarril J, Vlassara H. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104: 1287–1291.

  7. 7.

    Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med.2002;8: 337–46.

  8. 8.

    Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002; 26;99: 15596–601.

  9. 9.

    Peppa M, Uribarri J, Cai W, Lu M, Vlassara H. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis. 2004;43: 690–5.

  10. 10.

    Brownlee M. Negative consequences of glycation. Metabolism 2000;49, suppl 1: 9–3.

  11. 11.

    Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5: 561–8.

  12. 12.

    Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function — measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473–83.

  13. 13.

    Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 1984;101: 527–37.

  14. 14.

    Kalousova M, Sulkova S, Zima T, Deppisch R, Beck W, Bednarova V, Fortova M, Tesar V. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail. 2003;25: 277–86.

  15. 15.

    O’Brien J. Nutricional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr 1989;28: 211–248.

  16. 16.

    Peppa M, Uribarri J, Cai W, Lu M, Vlassara H. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis. 2004; 43: 690–5.

  17. 17.

    Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci. 1997;94: 6474–9.

  18. 18.

    Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043: 461–6.

  19. 19.

    Roberts MA, Thomas MC, Fernando D, MacMillan N, Power DA, Ierino FL. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol Dial Transplant 2006; EPUB ahead of print

  20. 20.

    Atalah E, Benavides X, Avila L, Barahona S, Cárdenas R. Dietary characteristics Nutritional features of elders living in poor communities of the Metropolitan Region of Chile. Rev. Med. Chile 1998;126: 489–496.

  21. 21.

    Sjoholm A, Nystrom T. Endothelial inflammation in insulin resistance. Lancet. 2005;365: 610–2

  22. 22.

    Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A. Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci. 2005;1043: 710–7.

  23. 23.

    DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol. 2004;4: 301–5.

  24. 24.

    Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis. 2006 65: 101–4.

Download references

Author information

Correspondence to M. P. de la Maza.

Additional information

Financing: FONDECyT Grant 1030597.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

de la Maza, M.P., Bravo, A., Leiva, L. et al. Urinary excretion of fluorescent advanced glycation end products (AGEs) in the elderly. J Nutr Health Aging 12, 222–224 (2008). https://doi.org/10.1007/BF02982625

Download citation

Keywords

  • Bone Mineral Content
  • Pentosidine
  • Diabetic Angiopathy
  • Nonenzymatic Glycosylation
  • Urinary AGEs